Cited by 226Hormonal Regulation and HypertensionRenin-Angiotensin System StudiesDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

Bochud, Murielle, Nussberger, Jürg, Bovet, Pascal, Maillard, Marc R., Elston, Robert C., Paccaud, Fred, Shamlaye, Conrad, Burnier, Michel·2006·Hypertension

DOI 10.1161/01.hyp.0000231338.41548.fc

Open this paper in CoChat — free account

Abstract

The aim of this study was to analyze the associations of plasma aldosterone and plasma renin activity with the metabolic syndrome and each of its components. We analyzed data from a family based study in the Seychelles made up of 356 participants (160 men and 196 women) from 69 families of African descent. In multivariable models, plasma aldosterone was associated positively (P < 0.05) with blood pressure in older individuals (interaction with age, P < 0.05) and with waist circumference in men (interaction with sex, P < 0.05) and negatively with high-density lipoprotein cholesterol, in particular in individuals with elevated urinary potassium excretion (interaction with urinary potassium, P < 0.05); plasma renin activity was significantly associated with triglycerides and fasting blood glucose. Plasma aldosterone, but not plasma renin activity, was associated with the metabolic syndrome per se, independently of the association with its separate components. The observation that plasma renin activity was associated with some components of the metabolic syndrome, whereas plasma aldosterone was associated with other components of the metabolic syndrome, suggests different underlying mechanisms. These findings reinforce previous observations suggesting that aldosterone is associated with several cardiovascular risk factors and also suggest that aldosterone might contribute to the increased cardiovascular disease risk in individuals of African descent with the metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.hyp.0000231338.41548.fc

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.
(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
McNeill, A. M., Rosamond, W. D., Girman, C. J., Golden, S. H., Schmidt, M. I., East, H. E., Ballantyne, C. M., & HEISS, G. M. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.385 · Cited by 1,051
Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms
NICHOLS, W. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.10.009 · Cited by 1,008
Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., & Participants, F. C. (2004) · Circulation · doi:10.1161/01.cir.0000112379.88385.67 · Cited by 864
Obesity-Associated Hypertension
Rahmouni, K., Correia, M., Haynes, W. G., & Mark, A. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 788
EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
Pitt, B., Wj, R., Zannad, F. M., Neaton, J. D., Martínez, F. A., Roniker, B., Bittman, R. M., Hurley, S., Kleiman, J. H., & Gatlin, M. R. (2003) · Cited by 708
Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study
Dekker, J. M., Girman, C. J., Rhodes, T., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., & Heine, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.516948 · Cited by 641
Weight Loss and the Renin-Angiotensin-Aldosterone System
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bäder, M., Luft, F. C., & Sharma, A. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000154361.47683.d3 · Cited by 627
Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons
Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W. F., Meigs, J. B., Rifai, N., Benjamin, E. J., & Levy, D. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033263 · Cited by 573
The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study
Ford, E. S. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.022 · Cited by 501
An Easy Radioimmunological Microassay of Renin Activity, Concentration and Substrate in Human and Animal Plasma and Tissues Based on Angiotensin I Trapping by Antibody
Poulsen, K., & JØRGENSEN, J. (1974) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-39-5-816 · Cited by 448
Human adipocytes secrete mineralocorticoid-releasing factors
Ehrhart‐Bornstein, M., Lamounier‐Zepter, V., Schraven, A., Langenbach, J., Willenberg, H. S., Barthel, A., Hauner, H., McCann, S. M., Scherbaum, W. A., & Bornstein, S. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336140100 · Cited by 442
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Pitt, B., White, H. D., Nicolau, J. C., Martínez, F. A., Gheorghiade, M., Aschermann, M., van Veldhuisen, D. J., Zannad, F. M., Krum, H., Mukherjee, R., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.038 · Cited by 396
The new biology of aldosterone
Connell, J., & Davies, E. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06017 · Cited by 367
Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy
Rossing, K., Schjoedt, K. J., Smidt, U., Boomsma, F., & Parving, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2106 · Cited by 298
High prevalence of primary aldosteronism in the Tayside hypertension clinic population
Lim, P. O., Dow, E., Brennan, G., Jung, R., & MacDonald, T. M. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001013 · Cited by 268
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70146-5 · Cited by 251
Visceral Obesity and Insulin Resistance Are Associated with Plasma Aldosterone Levels in Women
Goodfriend, T. L., Kelley, D. E., Goodpaster, B. H., & Winters, S. J. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00418.x · Cited by 234
Potentially high prevalence of primary aldosteronism in a primary-care population
Lim, P. O., Rodgers, P., Cardale, K., Watson, A., & MacDonald, T. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74868-6 · Cited by 228
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack, J. M., Oparil, S., Pratt, J. H., Roniker, B., Garthwaite, S. M., Kleiman, J. H., Yang, Y., Krause, S. L., Workman, D. L., & Saunders, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00054-8 · Cited by 223
Epoxy-Keto Derivative of Linoleic Acid Stimulates Aldosterone Secretion
Goodfriend, T. L., Ball, D. L., Egan, B. M., Campbell, W. B., & Nithipatikom, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000113294.06704.64 · Cited by 205
Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
Scheen, A. J. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70147-7 · Cited by 199
EVIDENCE THAT PRIMARY ALDOSTERONISM MAY NOT BE UNCOMMON: 12% INCIDENCE AMONG ANTIHYPERTENSIVE DRUG TRIAL VOLUNTEERS
Gordon, R. D., Ziesak, M. D., Tunny, T. J., Stowasser, M., & Klemm, S. A. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01687.x · Cited by 190
Blood pressure and hormone changes associated with weight reduction in the obese.
Sowers, J. R., Nyby, M. D., Stern, N., Beck, F. W., Baron, S. H., Catania, R. A., & Vlachis, N. (1982) · Hypertension · doi:10.1161/01.hyp.4.5.686 · Cited by 164
Aldosterone in obesity
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1998) · Endocrine Research · doi:10.3109/07435809809032689 · Cited by 143
Repeated administration of the converting enzyme inhibitor cilazapril to normal volunteers.
Nussberger, J., D'amore, T. F., Porchet, M., Waeber, B., Brunner, D. B., Brunner, H. R., Kler, L., Brown, A., & Francis, R. J. (1987) · PubMed · Cited by 128
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
Laragh, J. H. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)01301-7 · Cited by 127
Mechanisms of Hypertension
Freel, E. M., & Connell, J. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000132473.50966.14 · Cited by 121
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
Egan, B. M., Stepniakowski, K., & Goodfriend, T. L. (1994) · PubMed · doi:10.1016/0895-7061(94)p1710-h · Cited by 114
Role for aldosterone in blood pressure regulation of obese adolescents
Rocchini, A. P., Katch, V. L., Grekin, R. J., Moorehead, C., & Anderson, J. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90845-3 · Cited by 112
Arterial Pressure, Left Ventricular Mass, and Aldosterone in Essential Hypertension
El‐Gharbawy, A., NADIG, V., Kotchen, J. M., Grim, C. E., Sagar, K. B., Kaldunski, M. L., Hamet, P., Pausová, Z., Gaudet, D., Gossard, F., et al. (2001) · Hypertension · doi:10.1161/01.hyp.37.3.845 · Cited by 108
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans
Goodfriend, T. L., Egan, B. M., & Kelley, D. E. (1999) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80020-9 · Cited by 105
Repeated Administration of the Converting Enzyme Inhibitor Cilazapril to Normal Volunteers
Nussberger, J., D'amore, T. F., Porchet, M., Waeber, B., Brunner, D. B., Brunner, H. R., Kler, L., Brown, A., & Francis, R. J. (1987) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198701000-00007 · Cited by 103
Relationships Among Plasma Aldosterone, High-Density Lipoprotein Cholesterol, and Insulin in Humans
Goodfriend, T. L., Egan, B. M., Stepniakowski, K. T., & Ball, D. L. (1995) · Hypertension · doi:10.1161/01.hyp.25.1.30 · Cited by 98
Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy
Bovet, P., Shamlaye, C. F., Gabriel, A., Riesen, W., & Paccaud, F. M. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-9 · Cited by 94
Renin and Aldosterone Are Higher and the Hyperinsulinemic Effect of Salt Restriction Greater in Subjects With Risk Factors Clustering
Egan, B. M., Stepniakowski, K. T., & Goodfriend, T. L. (1994) · American Journal of Hypertension · doi:10.1093/ajh/7.10.886 · Cited by 94
Is there a role for the ob gene product leptin in essential hypertension?
Suter, P. M., Locher, R., Hasler, E., & Vetter, W. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00162-9 · Cited by 93
Hyperaldosteronism and Hypertension
Grim, C. E., Cowley, A. W., Hamet, P., Gaudet, D., Kaldunski, M. L., Kotchen, J. M., Krishnaswami, S., Pausová, Z., Roman, R., Tremblay, J., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154364.00763.d5 · Cited by 88
High Heritability of Ambulatory Blood Pressure in Families of East African Descent
Bochud, M., Bovet, P., Elston, R. C., Paccaud, F. M., Falconnet, C., Maillard, M. P., Shamlaye, C. F., & Burnier, M. (2005) · Hypertension · doi:10.1161/01.hyp.0000156538.59873.86 · Cited by 81
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders
Pisciotta, L., Hamilton‐Craig, I. R., Tarugi, P., Bellocchio, A., Fasano, T., Alessandrini, P., Bon, G. B., Siepi, D., Mannarino, E., Cattin, L., et al. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.11.009 · Cited by 69
Heritability of renal function in hypertensive families of African descent in the Seychelles (Indian Ocean)
Bochud, M., Elston, R. C., Maillard, M. P., Bovet, P., Schild, L., Shamlaye, C. F., & Burnier, M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2005.00055.x · Cited by 59
Highly sensitive microassay for aldosterone in unextracted plasma: comparison with two other methods.
Nussberger, J., Waeber, B., Brunner, H. R., Burris, J. F., & Vetter, W. (1984) · PubMed · Cited by 53
Metabolic syndrome and insulin resistance in the TROPHY sub-study: Contrasting views in patients with high-normal blood pressure
Egan, B. M., Papademetriou, V., Wofford, M. R., Calhoun, D. A., FERNANDES, J., RIEHLE, J., NESBITT, S., Michelson, E. L., & Julius, S. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.008 · Cited by 50
Role of the Metabolic Syndrome in Risk Assessment for Coronary Heart Disease
Kohli, P. (2006) · JAMA · doi:10.1001/jama.295.7.819 · Cited by 48
Serum aldosterone changes during hyperinsulinemia are correlated to body mass index and insulin sensitivity in patients with essential hypertension
Haenni, A., Reneland, R., Lind, L., & Lithell, H. (2001) · Journal of Hypertension · doi:10.1097/00004872-200101000-00014 · Cited by 26
Metabolic cardiovascular risk factors and the renin-aldosterone system in essential hypertension.
Lind, L., Lithell, H., WIDE, L. E., & Ljunghall, S. (1992) · PubMed · Cited by 23
Insulin resistance in essential hypertension is related to plasma renin activity
Lind, L., Reneland, R., Andersson, P.-E., Haenni, A., & Lithell, H. (1998) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000642 · Cited by 18
Changes in Plasma Lipids During Renin-Angiotensin System Blockade by Combination Therapy (Enalapril Plus Valsartan) in Patients With Diabetes and Hypertension
Gaudio, G. V., Guasti, L., Schizzarotto, A., Simoni, C., Crespi, C., Cimpanelli, M., Klersy, C., Grandi, A. M., Riganti, G., & Venco, A. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000157442.95354.0d · Cited by 15
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
Laragh, J. H. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)01282-1 · Cited by 8
Validation and application of U.N. model life tables against Thailand data, 1973-1983.
Podhipak, A. (1987) · PubMed · Cited by 6

Research works printed but not linked: 2

10.1161/hyp.25.1.30 · DOI
10.1161/hyp.37.3.845 · DOI

Sorted by citations

Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 735
Adipocyte-Derived Hormone Leptin Is a Direct Regulator of Aldosterone Secretion, Which Promotes Endothelial Dysfunction and Cardiac Fibrosis
Huby, A.-C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C. E., Bollag, W. B., Filosa, J. A., & de Chantemèle, E. J. B. (2015) · Circulation · doi:10.1161/circulationaha.115.018226 · Cited by 376
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
Sowers, J. R., Whaley-Connell, A., & Epstein, M. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00005 · Cited by 351
Aldosterone and end-organ damage
Brown, N. J. (2005) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000165889.60254.98 · Cited by 321
Enhanced Aldosterone Signaling in the Early Nephropathy of Rats with Metabolic Syndrome
Nagase, M., Yoshida, S., Shibata, S., Nagase, T., Gotoda, T., Ando, K., & Fujita, T. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080944 · Cited by 247

See all 226

Authors: Bochud, M., Nussberger, J., Bovet, P., Maillard, M. R., Elston, R. C., Paccaud, F., Shamlaye, C., & Burnier, M.
Affiliations: Centre Hospitalier Universitaire Vaudois (CH)
From the Department of Epidemiology and Biostatistics (M. Bochud, R.C.E.), Case Western Reserve University, Cleveland, Ohio; Institut Universitaire de Médecine Sociale et Préventive (M. Bochud, P.B., F.P.), Lausanne, Switzerland; Département de Médecine et Service de Néphrologie (J.N., M.R.M., M. Burnier), Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and the Ministry of Health (P.B., C.S.), Victoria, Seychelles.
ORCID: Bochud, Murielle
Bovet, Pascal
Elston, Robert C.
Burnier, Michel
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2006-08
Volume: 48
Issue: 2
Pages: 239-245
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/01.hyp.0000231338.41548.fc
OpenAlex: W2124037655
Cited by: 226
References: 55
Citations by year: 2026: 4 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 12 · 2021: 12 · 2020: 5 · 2019: 5 · 2018: 14 · 2017: 13 · 2016: 3 · 2015: 10 · 2014: 13 · 2013: 14 · 2012: 14
FWCI: 12.91
Type: journal article
Language: en
Open access: closed
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
IRIS (submittedVersion)
SERVAL (Université de Lausanne) (submittedVersion)
Funders: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
National Institute of General Medical Sciences (GM-28356)
National Center for Research Resources (RR-03655, P41RR003655)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: plasma aldosterone, plasma renin activity, metabolic syndrome, blood pressure, waist circumference, HDL cholesterol, potassium excretion, triglycerides, fasting blood glucose, cardiovascular risk, African ancestry
MeSH terms: Africa, Eastern, Aldosterone, Blood Pressure, Female, Humans, Male, Middle Aged, Regression Analysis, Renin, Risk Factors, Seychelles, Models, Statistical, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks